FDA approves Tecentriq and complementary diagnostic for metastatic urothelial carcinoma May 19, 2016 No Comments
FDA grants accelerated approval to nivolumab for patients with classical Hodgkin's lymphoma May 18, 2016 No Comments
FDA approves Nuplazid for hallucinations and delusions associated with Parkinson's disease psychosis May 2, 2016 No Comments
FDA grants accelerated approval to Venclexta for relapsed/refractory CLL with 17p deletion April 12, 2016 No Comments
RSS